Showing 981 - 1,000 results of 108,744 for search '(( i point decrease ) OR ( 5 ((nn decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.57s Refine Results
  1. 981
  2. 982
  3. 983
  4. 984

    A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

    Published 2015
    “…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”
  5. 985
  6. 986
  7. 987
  8. 988
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993

    Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies by Wenjing Dong (117921)

    Published 2016
    “…<i>5</i> (rs2227981) polymorphism is associated a strongly decreased risk of cancers. …”
  14. 994

    Decreases in time from AHP to threshold account for increased firing of cPLA<sub>2</sub>α<sup>-/-</sup> SCG neurons. by Liwang Liu (424650)

    Published 2018
    “…<p>(<b>A-B)</b> Examples of differences in AP firing during a 1 sec injection of 100 pA of current. …”
  15. 995
  16. 996
  17. 997

    S5 Fig - by Meghan J. Hirsch (16528311)

    Published 2023
    “…PA infections can lead to increased airway inflammation and lung tissue damage, ultimately contributing to decreased lung function and quality of life. Existing models of PA infection <i>in vitro</i> commonly utilize 1–6-hour time courses. …”
  18. 998

    A tropomyosin point mutant recapitulates the <i>rng8/9</i> deletion phenotype. by Omaya Dudin (3926825)

    Published 2017
    “…(G) Kymographs of Myo52-tdTomato showing multiple stable dots over >60s in <i>cdc8</i><sup><i>E104A</i></sup> mutant. (H) Myo51-3YFP fluorescence at the fusion site is decreased in <i>cdc8</i><sup><i>E104A</i></sup> mutant (N = 15); (***) P < 3 × 10<sup>−5</sup>, t-test. …”
  19. 999

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”
  20. 1000

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…At baseline, patients displayed overhydration (OH) with + 0.4 (-0.2 – 2.2) L/1.73m² which decreased by 0.5 (0.1 – 1.2) L/1.73m² after 6 months. …”